Harvard Bioscience (HBIO) Short term Debt (2013 - 2025)
Harvard Bioscience (HBIO) posted quarterly Short term Debt of $34.0 million for Q3 2025, up 841.96% year-over-year from $3.6 million in Q3 2024, and down 2.57% quarter-over-quarter from $34.9 million in Q2 2025.
Harvard Bioscience (HBIO) Short term Debt (2013 - 2025) Analysis & Trends
Harvard Bioscience (HBIO) has reported Short term Debt for 13 consecutive years, with $34.0 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Short term Debt rose 841.96% year-over-year to $34.0 million; the TTM figure through Sep 2025 stood at $34.0 million (up 841.96% YoY), while the FY2024 annual figure was $37.0 million, up 530.76% from the prior year.
- Short term Debt retreated to $34.0 million in Q3 2025 per HBIO's latest filing, from $34.9 million in the prior quarter.
- Across five years, Short term Debt topped out at $37.0 million in Q4 2024 and bottomed at $2.0 million in Q1 2021.
- Historically, Short term Debt has averaged $10.0 million across 5 years, with a median of $3.5 million in 2023.
- Annual changes were most pronounced in 2021 — Short term Debt retreated 29.82% — and 2025, when it jumped 866.61%.
- Harvard Bioscience's Short term Debt stood at $3.2 million in 2021, then climbed by 17.81% to $3.8 million in 2022, then soared by 53.74% to $5.9 million in 2023, then soared by 530.76% to $37.0 million in 2024, then decreased by 8.09% to $34.0 million in 2025.
- Business Quant data shows HBIO's Short term Debt at $34.0 million in Q3 2025, $34.9 million in Q2 2025, and $36.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 33.97 Mn |
| Jun 30, 2025 | 34.86 Mn |
| Mar 31, 2025 | 35.96 Mn |
| Dec 31, 2024 | 36.96 Mn |
| Sep 30, 2024 | 3.61 Mn |
| Jun 30, 2024 | 3.72 Mn |
| Mar 31, 2024 | 3.72 Mn |
| Dec 31, 2023 | 5.86 Mn |
| Sep 30, 2023 | 3.47 Mn |
| Jun 30, 2023 | 3.22 Mn |
| Mar 31, 2023 | 2.97 Mn |
| Dec 31, 2022 | 3.81 Mn |
| Sep 30, 2022 | 2.72 Mn |
| Jun 30, 2022 | 2.72 Mn |
| Mar 31, 2022 | 2.72 Mn |
| Dec 31, 2021 | 3.24 Mn |
| Sep 30, 2021 | 2.47 Mn |
| Jun 30, 2021 | 2.22 Mn |
| Mar 31, 2021 | 1.97 Mn |
| Dec 31, 2020 | 1.72 Mn |